Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea

Michael E. DeBakey VA Medical Center5 enrolled

Overview

The investigators propose to study intensively the bacteriology of feces in C. difficile associated diarrheal disease, using a variety of conventional and very up-to-date techniques.

Clostridium difficile associated colitis is an increasing problem in hospitals throughout the developed world; the number of cases has increased, and the failure to respond to conventional therapy has become far more common. The investigators have recently documented in the medical literature (Clin Infect Dis, June, 2005; Lancet Infect Dis, August, 2005). Possible reasons for failure of treatment include persistence of C. difficile and/or imbalance of other bacterial flora in the colon. The bacteriology of fecal flora in C. difficile associated diarrhea has not been studied.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Enterocolitis Pseudomembranous Colitis Antibiotic-Associated Colitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with antibiotic-associated diarrhea with a positive assay for C. difficile toxin * Patients with antibiotic-associated diarrhea with 3 negative assays for C. difficile toxin * Patients with antibiotic-associated diarrhea that has failed to respond to conventional therapy * Hospitalized patients who have received \>2 antibiotics and who have no symptoms of diarrhea or abdominal discomfort Exclusion Criteria: * none

Locations (2)

Johns Hopkins Medical Research Institute

Baltimore, Maryland, United States

Michael E. DeBakey Veterans Affairs Medical Center

Houston, Texas, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.